$147.97
0.7%
Price vs. AI Score (Last 150 days)
Data gathered: December 7
Data gathered: December 7
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 1,000 0% |
|
| Sentiment | 96 11.6% |
|
| Webpage traffic | 936,000 -7.3% |
|
| Employee Rating | 79 0% |
|
| Google Adspend | $4,022 365% |
|
| Google Trends | 28 -59.4% |
|
| Linkedin Employees | 52,820 N/A |
|
| Lobbying Cost | $250,000 0% |
|
| Patents | 476 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 657 3.6% |
|
| Facebook followers | 36,859 0% |
|
| Stocktwits Mentions | 65 441.7% |
|
| Stocktwits Subscribers | 30,327 0.1% |
|
| Twitter Followers | 79,296 0% |
|
| Youtube Subscribers | 5,720 0.2% |
|
| Instagram Followers | 32,150 0.1% |
|
| News Mentions | 3 50% |
|
| Reddit Mentions | 2 0% |
|
| ESG | 82 0% |
|
| Business outlook | 72 0% |
|
In the news
 |
PRESS DIGEST- Wall Street Journal - Dec. 7December 6 - Yahoo |
 |
Cerevel options trading surge before AbbVie deal news raises eyebrowsDecember 6 - Yahoo |
 |
The Magnificent 7 Aren't So Magnificent Right Now, BuyDecember 6 - SeekingAlpha |
 |
AbbVie to buy drug developer Cerevel for $8.7 billionDecember 6 - Yahoo |
 |
AbbVie to Buy Cerevel Therapeutics for $8.7 BillionDecember 6 - Yahoo |
|
UPDATE 3-AbbVie to buy drug developer Cerevel for $8.7 billionDecember 6 - Yahoo |
About AbbVie
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
| Price | $147.97 |
| Target Price | Sign up |
| Market Cap | $257B |
| Dividend Yield | 0.0429 |
| Industry | Drug Manufacturers |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 13.9B | 11.9B | 2.07B | 1.78B | 4.51B |
| Q2 '23 | 13.9B | 9.61B | 4.26B | 2.02B | 5.26B |
| Q1 '23 | 12.2B | 9.68B | 2.54B | 239M | 2.97B |
| Q4 '22 | 15.1B | 4.17B | 11B | 2.47B | 5.49B |
| Q3 '22 | 14.8B | 11.1B | 3.72B | 3.95B | 6.96B |
Insider Transactions
| GONZALEZ RICHARD A filed to sell 565,294 shares at $148.6. August 2 '23 |
| Sorg Elaine K. filed to sell 35,330 shares at $165. April 27 '23 |
| Sorg Elaine K. filed to sell 35,330 shares at $162. April 19 '23 |
| Siatis Perry C filed to sell 10,377 shares at $160. April 5 '23 |
| Sorg Elaine K. filed to sell 42,829 shares at $160. April 5 '23 |
Read more about AbbVie and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, lobbying cost, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, esg, business outlook.